| 1 |
Impact of vitamin D supplementation on cardio-metabolic status and androgen profile in women with polycystic ovary syndrome: placebo-controlled clinical trial |
|
| | Nearmeen M. Rashad,Azza H. Abd El-Fatah,Mohamed El-Bakry Lashin,Hala G. Abomandour,Reem M. Allam | | | Middle East Fertility Society Journal. 2020; 24(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome |
|
| | Nearmeen M. Rashad,Amal S. El-Shal,Hala G. Abomandour,Amr Mostafa Kamel Aboelfath,Mohamed el sayed Rafeek,Mohammad Samir Badr,Ayman E. Ali,Mohammed S. Yousef,Maha Abdelhamid Fathy,Mustafa taha Abdelfattah Sharaf el din | | | Journal of Ovarian Research. 2019; 12(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Serum visfatin as predictive marker of cardiometabolic risk in women with polycystic ovary syndrome |
|
| | Nearmeen M. Rashad,M.N. Ayman Abd-Elrahman,Amal S. El-Shal,Abdelaziz I. Amin | | | Middle East Fertility Society Journal. 2018; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes |
|
| | Moamar Al-Jefout,Nedal Alnawaiseh,Aiman Al-Qtaitat | | | Scientific Reports. 2017; 7(1) | | | [Pubmed] [Google Scholar] [DOI] | |
|
